Young TSPC-Derived Exosomal circPVT1 Ameliorates Aging-Impaired Cell Function via SIRT1/NF-κB.

IF 2.7 4区 医学 Q3 CELL & TISSUE ENGINEERING Tissue engineering. Part C, Methods Pub Date : 2024-01-01 DOI:10.1089/ten.TEC.2024.0057
Weifeng Han, Dongqiang Gu, Xiaoya Li, Hongguang Chen, Xu Tao, Lei Chen
{"title":"Young TSPC-Derived Exosomal circPVT1 Ameliorates Aging-Impaired Cell Function via SIRT1/NF-κB.","authors":"Weifeng Han, Dongqiang Gu, Xiaoya Li, Hongguang Chen, Xu Tao, Lei Chen","doi":"10.1089/ten.TEC.2024.0057","DOIUrl":null,"url":null,"abstract":"<p><p>Tendon stem/progenitor cell (TSPC) senescence is often associated with age-dependent tendon diseases and greatly reduces the capacities for tendon repair and replacement. Exosomes contain bioactive molecules and have been increasingly used in regenerative medicine. In the present study, we demonstrated the antiaging effects of young exosomes from circPVT1-overexpressing TSPCs at early passages (circPVT1-exo). These exosomes attenuated the phenotypes of aged TSPCs at late passages (L-TSPCs) by enhancing self-renewal and proliferation abilities, suppressing cell senescence, maintaining their tenogenic capacity, and weakening their osteogenic differentiation. Mechanistically, circPVT1-exo inhibited the NF-κB pathway and increased SIRT1 expression in L-TSPCs. Knockdown of SIRT1 reversed these effects as evidenced by increased senescence, decreased proliferation, and tenogenic differentiation. These results suggest that circPVT1-exo may ameliorate aging-impaired TSPC function by modulating the SIRT1/NF-κB pathway, suggesting that circPVT1-exo has therapeutic potential for age-related diseases.</p>","PeriodicalId":23154,"journal":{"name":"Tissue engineering. Part C, Methods","volume":" ","pages":"248-254"},"PeriodicalIF":2.7000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tissue engineering. Part C, Methods","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/ten.TEC.2024.0057","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CELL & TISSUE ENGINEERING","Score":null,"Total":0}
引用次数: 0

Abstract

Tendon stem/progenitor cell (TSPC) senescence is often associated with age-dependent tendon diseases and greatly reduces the capacities for tendon repair and replacement. Exosomes contain bioactive molecules and have been increasingly used in regenerative medicine. In the present study, we demonstrated the antiaging effects of young exosomes from circPVT1-overexpressing TSPCs at early passages (circPVT1-exo). These exosomes attenuated the phenotypes of aged TSPCs at late passages (L-TSPCs) by enhancing self-renewal and proliferation abilities, suppressing cell senescence, maintaining their tenogenic capacity, and weakening their osteogenic differentiation. Mechanistically, circPVT1-exo inhibited the NF-κB pathway and increased SIRT1 expression in L-TSPCs. Knockdown of SIRT1 reversed these effects as evidenced by increased senescence, decreased proliferation, and tenogenic differentiation. These results suggest that circPVT1-exo may ameliorate aging-impaired TSPC function by modulating the SIRT1/NF-κB pathway, suggesting that circPVT1-exo has therapeutic potential for age-related diseases.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
来源于年轻 TSPC 的外泌体 circPVT1 可通过 SIRT1/NF-κB 改善衰老受损的细胞功能。
肌腱干/祖细胞(TSPC)衰老通常与年龄依赖性肌腱疾病有关,并大大降低了肌腱修复和替代能力。外泌体含有生物活性分子,已越来越多地被用于再生医学。在本研究中,我们证实了来自早期表达 circPVT1 的 TSPCs 的年轻外泌体(circPVT1-exo)的抗衰老作用。这些外泌体通过增强细胞自我更新和增殖能力、抑制细胞衰老、维持细胞成腱能力和削弱成骨分化能力,减轻了晚期老化TPSCs(L-TSPCs)的表型。从机制上讲,circPVT1-exo抑制了NF-κB通路,并增加了SIRT1在L-TSPCs中的表达。抑制 SIRT1 可逆转这些影响,表现为衰老增加、增殖减少和成骨分化。这些结果表明,circPVT1-exo 可通过调节 SIRT1/NF-κB 通路改善衰老受损的 TSPC 功能,这表明 circPVT1-exo 具有治疗老年相关疾病的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Tissue engineering. Part C, Methods
Tissue engineering. Part C, Methods Medicine-Medicine (miscellaneous)
CiteScore
5.10
自引率
3.30%
发文量
136
期刊介绍: Tissue Engineering is the preeminent, biomedical journal advancing the field with cutting-edge research and applications that repair or regenerate portions or whole tissues. This multidisciplinary journal brings together the principles of engineering and life sciences in the creation of artificial tissues and regenerative medicine. Tissue Engineering is divided into three parts, providing a central forum for groundbreaking scientific research and developments of clinical applications from leading experts in the field that will enable the functional replacement of tissues. Tissue Engineering Methods (Part C) presents innovative tools and assays in scaffold development, stem cells and biologically active molecules to advance the field and to support clinical translation. Part C publishes monthly.
期刊最新文献
An Optimized Protocol for Multiple Immunohistochemical Staining of Fragile Tissue Samples. Design of an Innovative Method for Measuring the Contractile Behavior of Engineered Tissues. Enhancing Gingival-Derived Mesenchymal Stem Cell Potential in Tissue Engineering and Regenerative Medicine Through Paraprobiotics. Simple Methodology to Score Micropattern Quality and Effectiveness. Autoinduction-Based Quantification of In Situ TGF-β Activity in Native and Engineered Cartilage.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1